Donor lymphocyte infusions to displace residual host hematopoietic cells after allogeneic bone marrow transplantation for beta-thalassemia major.
OBJECTIVE
Donor lymphocyte infusion (DLI) was used to reverse relapse after allogeneic bone marrow transplantation (BMT) in a patient with beta-thalassemia major.


METHODS
The patient with unstable mixed chimerism after BMT was treated with graded increments of donor lymphocytes (10(5) T cells/kg to 5 x 10(7) T cells/kg) to displace residual hematopoietic host cells.


RESULTS
DLI resulted in complete donor-derived reconstitution of the hematopoietic compartment. The patient developed mild graft-versus-host disease (GVHD) that could be controlled by steroid treatment.


CONCLUSIONS
This case report shows that DLI can effectively eradicate host stem cells in mixed chimeras after BMT in nonmalignant hematopoietic diseases.
Aker
M
M
Department of Pediatrics, Hadassah University Hospital, Jerusalem, Israel.
Kapelushnik
J
J
Pugatsch
T
T
Naparstek
E
E
Ben-Neria
S
S
Yehuda
O
O
Amar
A
A
Nagler
A
A
Slavin
S
S
Or
R
R
D016026:Bone Marrow Transplantation / Q000276:immunology*; D002675:Child, Preschool; D002678:Chimera; D006086:Graft vs Host Disease / Q000188:drug therapy; D006412:Hematopoietic Stem Cells / Q000276:immunology*; D006801:Humans; D017710:Lymphocyte Transfusion; D008297:Male; D017086:beta-Thalassemia / Q000628:therapy*